DALLAS — Osmotics, the Denver-based skin care company known for its techno-based antiaging and dermatitis products, thinks it has an antidote to prevent adverse reactions to smallpox vaccinations, a hot topic with talk of chemical warfare and the Iraqi threat.

The company’s findings were presented Thursday at a news conference in New York.

To Read the Full Article
SUBSCRIBE NOW

Tap into our Global Network

Of Industry Leaders and Designers

load comments
blog comments powered by Disqus